FAQ
Liposomal CBD is cannabidiol (CBD) encapsulated in tiny fat-like particles called liposomes. These help the body absorb CBD more efficiently—delivering up to 5× higher bioavailability compared to standard CBD oils. This means more of the active ingredient reaches the bloodstream, where it can support everyday wellbeing.
EquiCeutica stands out by leveraging the latest scientific advancements to create pharmaceutical-grade CBD products for horses, dogs, cats, and humans. Our formulations and dosages are supported by peer-reviewed research, ensuring exceptional effectiveness. Through innovative development, we have produced a superior CBD product with outstanding bioavailability, providing targeted relief while minimizing liver metabolism and residue. We partner with a leading UK MHRA-accredited manufacturer for human and veterinary medications, using the same scientifically validated CBD distillate for equine, canine, and feline. Additionally, we are at the forefront of liposomal nano-encapsulation technology, setting new standards in both veterinary and human spaces for enhanced absorption and effectiveness.
Yes. EquiCeutica’s liposomal CBD is specifically formulated for enhanced safety and compatibility. Unlike traditional CBD oils, our liposomal delivery system bypasses first-pass metabolism in the liver — meaning it’s less likely to interfere with other medications. Because the CBD is encapsulated in liposomes, it enters the bloodstream more directly and avoids the enzyme pathways (like CYP450) that many drugs rely on. However, we always recommend speaking with your healthcare provider before introducing any new supplement.